Somar Leads EmpiRx Health's Sales Activities to Accelerate and Scale the Company's Strong Growth as the Pharmacist Led PBM Leader EmpiRx Health, the leading pharmacist led pharmacy benefits management (PBM) company, today announced that it has named Jeff Somar Chief Commercial Officer. A seasoned healthcare industry executive, Somar is responsible for leading EmpiRx Health's sales […]
During National Prostate Health Month in September, Olympus Corp. of the Americas is proud to announce the new iTind™ Center of Excellence (COE) Program, which is designed to enhance care, experience and outcomes for men suffering from symptoms associated with benign prostatic hyperplasia (BPH), known as enlarged prostate. https://mma.prnewswire.com/media/2771307/Olympus_Inaugural_iTind_Center.jpg Urologists included in the iTind Center
Washington, D.C., Sept. 11, 2025 (GLOBE NEWSWIRE) — On April 2, 2025, while headlines focused on tariffs, “something far more powerful was unfolding behind the scenes,” according to a newly released presentation. President Trump and his closest advisors were laying the foundation for what Buck Sexton calls “Manhattan 2”–a radical initiative designed to reassert America's
White House Insider and Former CIA Officer Breaks Silence on “Manhattan 2” Interview Exposes Sweeping $2.2 Trillion AI Plan With Unprecedented Implication GlobeNewswire September 11, 2025 Washington, D.C., Sept. 11, 2025 (GLOBE NEWSWIRE) — On April 2, 2025, while headlines focused on tariffs, “something far more powerful was unfolding behind the scenes,” according to a
Sophont, a medical AI startup, announced the closing of its $9.22M pre-seed and seed funding round led by Kindred Ventures, with participation from Upfront Ventures, Delphi Ventures, Jeff Dean (GoogleDeepMind), Logan Kilpatrick (Google DeepMind), Lukas Biewald (Weights & Biases), Clément Delangue (Factorial Capital, Hugging Face), and other investors. https://mma.prnewswire.com/media/2771364/Sophont_cofounders.jpg Sophont is building multimodal medical foundation
(NYSE:NVO), LOS ANGELES, Sept. 11, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming September 30, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO) securities between
https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish
Deadline Alert: Novo Nordisk A/S (NVO) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit GlobeNewswire September 11, 2025 LOS ANGELES, Sept. 11, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming September 30, 2025 deadline to file a lead plaintiff motion in
NEW YORK, NY / ACCESS Newswire / September 11, 2025 / If you suffered a loss on your Charter Communications, Inc. (NASDAQ:CHTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/charter-communications-inc-lawsuit-submission-form?prid=166729&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / September 11, 2025 / If you suffered a loss on your Nutex Health Inc. (NASDAQ:NUTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nutex-health-inc-lawsuit-submission-form?prid=166728&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or